logo
Deadly chocolate recalled in Midwest states over ingredient that could KILL

Deadly chocolate recalled in Midwest states over ingredient that could KILL

Daily Mail​17-06-2025
Dark chocolate almonds have been recalled in six states due to 'undeclared' cashews.
Grocery chain Meijer announced Monday it is voluntarily recalling several packages of Frederik's Dark Chocolate Almonds because they may also have chocolate-covered cashews, which are not on the label.
The chain, which operates 272 stores in six states, initiated the recall after a customer informed them of the error.
The recall includes Frederik's by Meijer Dark Chocolate Almonds (12 oz) and Frederik's Dark Chocolate Almonds 8-count (1.5 oz).
The former has sell-by dates of May 7, 2026, and May 28, 2026, while the latter has a sell-by date of May 5, 2026. The UPC codes are 7-08820-68730-1 and 7-19283-11923-0.
The products were recalled in all of the states where Meijer stores are located, which are Michigan, Indiana, Illinois, Ohio, Kentucky and Wisconsin.
The FDA said in its announcement: 'People who have an allergy or severe sensitivity to cashews run the risk of a serious or life-threatening allergic reaction if they consume the product.'
No illnesses have been reported so far, and the FDA has not yet assigned a classification to the recall. However, the agency could label it 'Class I' due to the life-threatening risk.
A Class I recall describes 'a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death,' according to the FDA.
Nut allergies are one of the leading triggers of anaphylaxis, a severe allergic reaction that causes the immune system to release a flood of antibodies to ward off the foreign invader.
This causes skin reactions like hives, low blood pressure, dizziness, fainting, and the airways to close in and restrict breathing. It kills 150 to 200 Americans with food allergies every year.
About one percent of Americans, or 3.3million, are allergic to tree nuts like cashews, almonds, hazelnuts, pecans and pistachios. Around one in five of these people are specifically allergic to cashews.
Cashew allergic reactions can cause hives, stomach pain and vomiting.
The FDA has urged customers who are allergic or sensitive to cashews to avoid eating the products and return them to the customer service desk at any Meijer store for a full refund.
Customers with questions can contact Meijer at 800-543-3704 from 7am-1am. EDT daily.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health warning issued as source of serious bacteria outbreak revealed
Health warning issued as source of serious bacteria outbreak revealed

The Independent

timean hour ago

  • The Independent

Health warning issued as source of serious bacteria outbreak revealed

Public health officials have issued a warning regarding an outbreak of Campylobacter and E. coli linked to raw milk from an unnamed farm in Florida. The outbreak has affected 21 individuals, including six children under 10, resulting in seven hospitalisations and two severe complications. The Florida Department of Health expressed concerns about sanitation practices at the implicated farm, noting that raw milk is only legally sold for non-human consumption in the state. Federal health agencies, including the CDC and FDA, strongly advise against consuming raw milk due to significant health risks from various pathogens, emphasising that pasteurisation eliminates these dangers. Despite scientific consensus on the risks, raw milk has gained popularity among some groups, with Health and Human Services Secretary Robert F. Kennedy Jr. being a consumer, though his administration has not delivered the regulatory changes raw milk advocates hoped for.

US FDA names Sean Keveney as chief counsel
US FDA names Sean Keveney as chief counsel

Reuters

timean hour ago

  • Reuters

US FDA names Sean Keveney as chief counsel

Aug 4 (Reuters) - The U.S. Food and Drug Administration on Monday named Sean Keveney as its new chief counsel, placing him in charge of overseeing all legal matters at the health agency. Keveney most recently served as acting general counsel at the Department of Health and Human Services, where he led legal efforts to implement key administration priorities and regulatory reforms under the Make America Healthy Again agenda. Before joining HHS, Keveney spent nearly 16 years at the Department of Justice's Civil Rights Division. He replaces Robert Foster, who was serving in an interim capacity following the abrupt resignation of former chief counsel Hilary Perkins, just two days after her appointment was announced. Perkins stepped down after Republican Senator Josh Hawley of Missouri criticized her selection, describing her as "pro-abortion" and supportive of vaccine mandates. Foster, who has advised U.S. health secretary Robert F. Kennedy Jr. on vaccine regulation, will now assume the role of acting general counsel at HHS, the department confirmed.

Hims and Hers misses revenue estimates on decreasing wholesale demand
Hims and Hers misses revenue estimates on decreasing wholesale demand

Reuters

time2 hours ago

  • Reuters

Hims and Hers misses revenue estimates on decreasing wholesale demand

NEW YORK, Aug 4 (Reuters) - Hims and Hers Health (HIMS.N), opens new tab missed Wall Street estimates for second-quarter revenue on Monday, hit by weakness in its wholesale business, sending its shares down 9% in extended trading. The results follow the U.S. Food and Drug Administration's sunset deadline for telehealth companies to end mass compounding. Hims and rival telehealth companies have launched programs that offer "personalized" versions of semaglutide, the active ingredient in weight-loss drug Wegovy, at doses not accessible through the branded manufacturers. Wegovy maker Novo Nordisk (NVOH.P), opens new tab has characterized mass personalization as illegal, and analysts have questioned whether Hims will be able to sustain its growth following the crackdown. Hims and Hers reported quarterly revenue of $544.8 million, missing analysts' average expectation of $551.6 million. The company's wholesale unit, which represents non-prescription product sales to retailers through wholesale purchasing agreements, posted quarterly sales of $7.95 million, down 10% from a year ago. On a year-over-year basis, subscribers increased 31% to 2.44 million in the second quarter. Subscribers rose 38% in the first three months of the year. The company reported a quarterly profit of 17 cents per share, higher than the average analyst estimate of 15 cents, according to LSEG data.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store